Affiliate disclosure: Some links below are affiliate links. If you sign up through one of these links, we may earn a commission at no extra cost to you. This does not influence our comparisons or recommendations.
GLP-1 medications like Ozempic, Wegovy, and Mounjaro aren't cheap. Without insurance, you're looking at brand-name prices that can exceed $1,000 per month. But there's good news: if you know where to look, you can access GLP-1 medications for a fraction of that cost.
This guide walks you through every affordable option available in 2026—from manufacturer programs to compounded alternatives—so you can find the lowest price without sacrificing safety or quality.
GLP-1 medications without insurance typically cost between $117 and $1,500 per month, depending on the medication type, dose, and how you purchase it. The widest variation happens between brand-name drugs at full price and compounded or discounted alternatives.
Here's what the price floor looks like across the most common options:
If you want an FDA-approved GLP-1 at the lowest possible price, Wegovy oral semaglutide is your answer. Through August 31, 2026, Novo Nordisk is running an introductory offer that lets eligible self-pay patients get the daily pill for just $149/month for the first two months. After the promotion ends, pricing is expected to stabilize around $199–$349/month.
The main trade-off: the oral version may not be quite as effective as weekly injectables for some patients, and you have to take it daily. But for budget-conscious shoppers, this is the sweet spot for FDA-approved safety with a rock-bottom price.
Compounded semaglutide is the absolute cheapest GLP-1 option you can find, sometimes starting as low as $117 per month through licensed telehealth providers. But it comes with a crucial caveat: it's not FDA-approved.
Compounded medications are made by licensed pharmacists in accordance with a doctor's prescription, and the FDA does oversee compounding facilities. However, they're not manufactured under the same rigorous standards as brand-name drugs, and your insurance won't cover them.
When compounded makes sense: You're budget-constrained, have had success with semaglutide before, and you're comfortable with slightly less regulatory oversight.
When to avoid compounded: You're new to GLP-1s and want the assurance of an FDA-approved medication, or you have concerns about product consistency.
If you want to stick with a brand-name, FDA-approved medication but minimize cost, Zepbound (tirzepatide, made by Eli Lilly) in single-dose vial format beats the pre-filled pen versions by $200–$500 per month.
Pre-filled Zepbound pens can cost over $1,000 per month. The same medication in vial form through Lilly's Direct program costs $349–$499/month depending on dose. You inject from the vial yourself using a standard syringe, which takes practice but saves significant money.
Novo Nordisk's patient assistance program makes Ozempic (semaglutide injection) available for $499/month for eligible self-pay patients. This is higher than Zepbound vials but can be a good alternative if:
Even with the same medication and dose, pharmacy prices can vary by $100–$200 per month. Always compare prices across multiple chains before filling your prescription:
Pricing and promotions change frequently. Before you commit to any option, verify current pricing:
Price isn't the only factor. Before choosing your GLP-1, ask:
The cheapest GLP-1 without insurance is compounded semaglutide at $117–$250/month. If you want FDA approval, Wegovy oral at $149/month is unbeatable. For a brand-name injectable, Zepbound vials at $299–$449/month offer the best value.
Don't pay list price. Use our tool to find your lowest-cost, safest option today.
© 2026 Olson Coaches|About|Privacy Policy|Terms of Use|Contact|Pricing Guides
Guides:Cheapest GLP-1 Without Insurance·Ozempic vs Mounjaro Cost·Self-Pay Options
Tools:Medicare Bridge eligibility checker·Provider legitimacy checker
Medicare:Bridge Program 2026 guide
Affiliate Disclosure: We may earn commissions from partner links.
Sources: TrumpRx.gov, GoodRx, NovoCare, LillyDirect, CMS, KFF, FDA.gov